Synergistic Lethality Effects of Apatinib and Homoharringtonine in Acute Myeloid Leukemia.
Yuan-Fei ShiDandan XuYi XuHuafei ShenYan ZhangXiujin YeJie JinDawei CuiWanzhuo XiePublished in: Journal of oncology (2022)
Our preclinical data demonstrate that Apatinib combined with HHT exerts a better antileukemia effect than Apatinib alone by inhibiting the VEGFR-2 signaling pathway, suggesting the potential role of Apatinib and HHT in the treatment of AML. This study provides clinicians with innovative combination therapies and new therapeutic targets for the treatment of AML.